title: Clinical development and approval of second generation ALK inhibitors for ALK rearranged lung cancer.
authors: Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
authors: Daniel B
authors: DB
authors: Costa